Michael Mulkerrin

Michael Mulkerrin serves as Chief Technical Operations Officer at ADC Therapeutics. ADC Therapeutics operates in the research sector with approximately 320.0 employees. The company is headquartered in Redwood City, California. ADC Therapeutics generates annual revenue of 69000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Salesforce Route 53 Mimecast Outlook Formstack Vimeo Google Font API Google Analytics Cedexis Radar LiveRamp Adobe Media Optimizer Mobile Friendly Typekit reCAPTCHA WordPress.org Google Tag Manager Remote

biotechnology: pharmaceutical preparations health care biotechnology research antibody drug conjugates cancer treatment hematology solid tumors loncastuximab tesirine-lpyl adct-602 targeted therapy cytotoxic molecule therapeutic window innovative collaborations pbd technology fda approval biologics license application targeted investments adc portfolio cytotoxic activity dna topoisomerase i clinical trials phase 3 trials tumor cells dosing regimens patient outcomes r&d capabilities biotechnology startup oncology research cancer patients ethical practices innovative science research grants early access programs employee wellness program medical affairs camaraderie entrepreneurial spirit regulatory compliance global presence equity grants comprehensive benefits package health insurance collaborative environment clinical data strategic partnerships industry veterans cancer treatment innovations compensation package work-life balance ongoing learning employee development stock purchase plan quality assurance biotechnology adcs hematological malignancies oncology targeted therapies precision medicine innovative payloads pyrrolobenzodiazepine technology investigational drugs zynlonta oncologists healthcare professionals research & development market presence u.s. market european market cancer therapies patient-centric approach unmet medical needs competitive landscape biopharmaceuticals drug development therapeutic innovation advanced cancer treatments oncology market health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Michael Mulkerrin in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at ADC Therapeutics.

How do I reach Michael Mulkerrin directly?

Michael Mulkerrin's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technical Operations Officer at ADC Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Michael Mulkerrin work for?

Michael Mulkerrin is Chief Technical Operations Officer at ADC Therapeutics, a company in the research sector with 320.0 employees. The company is based in Redwood City, California.

Can I pitch or sell to Michael Mulkerrin?

As Chief Technical Operations Officer at ADC Therapeutics, Michael Mulkerrin is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Michael Mulkerrin directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Michael Mulkerrin in?

Michael Mulkerrin works in the research industry as Chief Technical Operations Officer at ADC Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Michael Mulkerrin's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michael Mulkerrin's profile is kept up-to-date with the latest available information.

Last updated: May 11, 2026